DEBASISA MOHANTY
@deb030903
Director, National Institute of Immunology, New Delhi, India
ID: 3250249016
20-06-2015 02:30:28
174 Tweet
273 Takipçi
158 Takip Edilen
Dholpur Gets First Science Centre in Aspirational Districts Push: Union Minister Dr Jitendra Singh inaugurates Youth Innovation Hub 💠PM Narendra Modi had transformed the “backward district” narrative into “aspirational districts", says Minister 💠Science Belongs to the Last
We are delighted to announce that iBRIC+ ranks #1 in the Biological Science Category and #3 in the Health Science Category in India as per Nature Index 2025. Read more: nature.com/nature-index/i… Dr Jitendra Singh Rajesh Gokhale BRIC DBT DSTIndia
🌍 #InternationalYouthDay2025 | 12th August From classrooms to advanced labs, India’s youth are enabling the nation’s biotech future. Through Department of Biotechnology's visionary programmes, we’re nurturing innovators, researchers, and leaders shaping a sustainable future. #YouthInBiotech
Hon’ble PM Shri @NarendraModi ji's clarion call from the Red Fort 🇮🇳 — urging youth to join hands in implementing the #BioE3 Policy and shaping India’s future through science, innovation & enterprise. #HappyIndependenceDay2025 #ViksitBharat #AmritKaal Department of Biotechnology BRIC DBT
The inimitable Prof. P. Balaram at BRIC–NII’s 39th Foundation Day! Foundation Day Lecture: Evolutionary Inventions and Innovations that Drove the Rise of Chemistry, the Birth of Biology, and Determined Human History 📅 6 Oct | 🕙 10 AM 📍GP Talwar Auditorium, BRIC-NII Department of Biotechnology
🚀 Official Launch | D.E.S.I.G.N. for BioE3 Challenge Empowering Youth to Solve Critical Issues of their TIMES Launched by Dr. Rajesh Gokhale, Secretary, Department of Biotechnology during the Curtain Raiser Event of the Emerging Science, Technology and Innovation Conclave (#ESTIC2025), along
Triple-negative breast cancer #TNBC lacks targeted therapies. In a collaborative study, researchers from BRIC–NII, Amity University Gurugram, RCB, and Ashoka University demonstrate that a hydrogel-based docetaxel–carboplatin (DTX–CPT–Gel) therapy curbs tumor growth by rewiring
The Indo-French workshop opened with insightful remarks from leaders: Dr Debasisa Mohanty, Director, BRIC-NII Dr Pushkar Sharma, Senior Scientist, BRIC-NII Dr François Trottein, CIIL Dr Nicolas Gascoin, Deputy Counsellor for Cooperation and Cultural Affairs, French Embassy in India 🇫🇷🇪🇺 Dr
French Embassy in India 🇫🇷🇪🇺 Department of Biotechnology CNRS 🌍 Inserm BRIC DBT Dr Jitendra Singh DEBASISA MOHANTY Pushkar Sharma A compelling keynote by Dr. Arvind Sahu RCB on “Viral Teachings on Complement Regulation”—revealing how pathogens exploit immune mechanisms and what this means for host–pathogen biology. A highlight of Day 1 at the Indo–French Workshop. #ComplementBiology